Markets & Regulations

Pic:getty/sanjeri

Pfizer to acquire immuno-oncology company Trillium

By Rachel Arthur

Pfizer will acquire Trillium Therapeutics Inc.; strengthening its work in oncology with the addition of next-generation, investigational immuno-therapeutics for hematological malignancies.

Follow us

Products

View more

Webinars